Results

Total Results: 1,895 records

Showing results for "drug".

21. Final Progress Report: Gastrointestinal Safety of Antithrombotic Drug Regimens (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/abraham-report.pdf
    January 01, 2024 - Final Progress Report: Gastrointestinal Safety of Antithrombotic Drug Regimens 1 Project Title: Gastrointestinal … Safety of Antithrombotic Drug Regimens Grant Number: 5RO1HSO25402-04 Principal Investigator: Neena … Drug combination subcohorts were stratified by cardiac conditions, including acute coronary syndrome … Estimates of OTC drug prevalence were obtained from the Natural Language Processing (NLP) information … a single cardiovascular risk group (i.e., nonvalvular atrial fibrillation patients) when studying drug

22. Off-Label Drugs: What You Need to Know | Agency for Healthcare Research and Quality
    www.ahrq.gov/patients-consumers/patient-involvement/off-label-drug-usage.html
    September 01, 2015 - Off-Label Drugs: What You Need to Know Off-label prescribing is when a physician gives you a drug … Food and Drug Administration (FDA) has approved to treat a condition different than your condition. … Antipsychotic Medications Understanding Investigational Drugs and Off Label Use of Approved Drugs Off-Label Drug

23. Final Progress Report: Enhancing the Detection and Management of Adverse Drug Events in the Nursing Home (pdf file)
    www.ahrq.gov/sites/default/files/2024-02/handler-report.pdf
    January 01, 2024 - Monitors and reports significant drug-drug interactions……………………………………………... 1 2 3 … Monitors effectiveness of drug therapy……………… 1 2 3 4 5 1 2 3 4 5 7. … Age‐related Changes in Antidepressant Pharmacokinetics and Potential Drug‐Drug Interactions: A Comparison … Potential Prescription Drug Misuse in Assisted Living.   … Adverse drug reactions and current state of drug regimen review in nursing facilities: need for a change

24. Final Progress Report: Surveillance for Adverse Drug Events in Ambulatory Pediatrics (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/bailey-kilbridge-report.pdf
    January 01, 2024 - Adverse Drug Events in Ambulatory Care. … The criteria for this rule had terms including “adverse drug event,” “adverse drug reaction,” “adverse … drug effect,” “drug reaction,” and “drug side effects.” … Hospital admissions due to adverse drug reactions. … Pharmacoepidemiol Drug Saf 2001; 10(2):113-119.

25. Emergency Visits for Opioid Use Rose White Treatment for Illicit Drug Use Remained Unchanged (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/qdr-data-spotlight-opioids-edvisits-tx.pdf
    August 11, 2021 - Emergency Visits for Opioid Use Rose White Treatment for Illicit Drug Use Remained Unchanged … Emergency Visits for Opioid Use Rose While Treatment for Illicit Drug … Results From the 2019 National Survey on Drug Use and Health: Detailed Tables. … Provisional Drug Overdose Death Counts. … Int J Drug Policy. 2015 Apr;26(4):380-387. https://pubmed.ncbi.nlm.nih.gov/25477284/.

26. Care Coordination | Agency for Healthcare Research and Quality
    www.ahrq.gov/topics/care-coordination.html
    January 01, 2014 - have difficulty reconciling and managing medications after a hospital discharge, leading to adverse drug … prescribing clinicians, track the impact of medications on symptoms, view medication precautions and drug-drug

27. Meeting Minutes, November 2018 | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/events/nac/2018-11-nac/nacmtg1118-minutes.html
    April 01, 2019 - The Food and Drug Administration is supporting a drug competition plan and a biosimilar drug plan. … MEPS is collecting and disseminating representative prescription drug data. … Hill presented graphs of trends in drug prices, out-of-pocket payments, and drug types (single source … For drug expenditure by type of drug, the decade from 2005 to 2015 saw regular yearly increases in the … drug prescriptions).

28. Final Progress Report: TOP-MEDS CERT: Tools for Optimizing Medication Safety (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/lambert-report.pdf
    January 01, 2024 - , and patient-centered drug information. … Key Words: Medication safety, adverse drug events, statistical methods, opioid dosing, simulation, drug … In the context of drug safety, the discrete-time survival model allows us to use drug exposure as a … Regulators and drug companies seeking a validated pre-approval method for identifying confusing drug … to Drug A exceeds a threshold; and (3) Drug B has an indication that matches an active diagnosis (e.g

29. Medicare Version of the Health Plan Survey | Agency for Healthcare Research and Quality
    www.ahrq.gov/cahps/surveys-guidance/hp/about/Medicares-CAHPS-HP-Survey.html
    December 01, 2023 - The Medicare Survey includes versions for Medicare Advantage plans (including PPOs), Prescription Drug … Rating of Drug Plan (MA-PD and PDP). … Learn about the Medicare Advantage and Prescription Drug Plan CAHPS Survey .

30. Final Progress Report: Off-Label Prescribing: Comparative Evidence, Regulation, and Utilization (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/kesselheim-report.pdf
    January 01, 2024 - of off-label drug use and medical, social, legal, and economic factors that influence off-label drug … Drug Safety. 2002;25:1- 5. 5 Rayburn W, Turnbull G. … Pharmacoepidemiol Drug Saf. 2005;14(9):629-638. 9 Food and Drug Administration. … ineffective off-label drug use, potentially dangerous off-label drug use, and off-label uses encouraged … Drug labels: a flawed source of data for studying orphan drug approvals.

31. About AHRQ's Work on Opioids and Substance Use Disorders | Agency for Healthcare Research and Quality
    www.ahrq.gov/opioids/about.html
    August 01, 2021 - About AHRQ's Work on Opioids and Substance Use Disorders Deaths from drug overdoses have risen … The rise in drug overdose deaths was initially driven by misuse of prescription opioids but is now also

32. Final Progress Report: Clinical Prediction of Hepatotoxicity & Comparative Hepatic Safety of Medications (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/lo-report.pdf
    January 01, 2024 - suspected drug-induced liver injury within KPNC at the initial drug-induced liver injury diagnosis … Drug-induced liver disorders: implications for drug development and regulation. … US Food and Drug Administration. … Rules and laws of drug hepatotoxicity. Pharmacoepidemiol Drug Saf 2006;15:231-3. 13. Lewis JH. … US Food and Drug Administration Drug Safety Communication: FDA limits usage of Nizoral (ketoconazole)

33. Final Progress Report: Clinical importance of the drug interaction between statins and CYP3A inhibitors (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/strom-report.pdf
    January 01, 2024 - inhibitors, renal dysfunction, hepatic dysfunction, muscle toxicity, myopathy, myalgia, rhabdomyolysis, drug-drug … 11% 10% 10% 8% 11% 10% Hypertension drug 63% 64% 57% 60% 63% 65% Thyroid drug 7% 7% 6% 6% 7% 7% Gemfibrozil … pharmacodynamic alterations of 3-hydroxy- 3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug-drug … Drug Interactions: Cytochrome P450 Drug interaction table: Indiana University School of Medicine 2007 … Drug Safety. 2008;31(3):231-240.

34. CHIPRA 212 Appendix 1 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-appendix-1.pdf
    January 24, 2025 - Accuneb Asthma Drug Albuterol Sulfate Asthma Drug Proventil Asthma Drug ProAir HFA Asthma Drug ReliOn … Ventolin HFA Asthma Drug Ventolin HFA Asthma Drug Qvar Asthma Drug Budesonide Asthma Drug Pulmicort … Respules Asthma Drug Symbicort Asthma Drug Alvesco HFA Asthma Drug Cromolyn Sodium Asthma Drug Flovent … Diskus Asthma Drug Advair Diskus Asthma Drug Dulera Asthma Drug Levalbuterol Asthma Drug Xopenex … Asthma Drug Metaproterenol Sulfate Asthma Drug Asmanex Twisthaler 30 Dose

35. Infographic - More Opioid-Related Emergency Visits, No Change in Illicit Drug Use Treatment (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/data/infographics/emergency-visits-opioids.pdf
    June 02, 2025 - Infographic - More Opioid-Related Emergency Visits, No Change in Illicit Drug Use Treatment This Is … Health Services Administration, Center for Behavioral Health Statistics and Quality, National Survey on Drug … More Opioid-Related Emergency Visits, No Change in Illicit Drug Use Treatment Emergency Department … Visits for Opioid- Related Care Getting Treatment for Illicit Drug Use When Needed People Ages

36. Final Progress Report: Prescribing Errors in Ambulatory Pediatric Care (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/basco-report.pdf
    January 01, 2024 - For 11 LASA drug pairs, we identified patients who experienced a first dispensing of one drug in the … LASA errors are the erroneous prescription or delivery of a drug because the name of the drug (generic … (a "usual drug"). … and then presented with a first prescription for the paired drug within 6 months of a usual drug. … Either drug in a LASA pair could serve as the usual drug.

37. Final Progress Report: Optimizing OTC labels for older adults (pdf file)
    www.ahrq.gov/sites/default/files/2024-11/becker-bix-report.pdf
    January 01, 2024 - Results: Survey results indicated that drug-drug and drug-diagnosis warnings were critical to ADE prevention … In brief, the information in this critical subset were the warnings concerning drug/drug and drug-diagnosis … The highlighting treatment will involve highlighting the active ingredient and all drug- drug and drug-diagnosis … as a potential drug- drug interaction, a potential drug-diagnosis interaction, or another problem (e.g … /drug and drug/diagnosis warnings) were most important.

38. Final Progress Report: Encoding and Processing Patient Allergy Information in EHRs (pdf file)
    www.ahrq.gov/sites/default/files/2024-07/zhou-report.pdf
    January 01, 2024 - For example, a mention of a drug name may be in reference to that drug as an allergen, but it could … For example, if a drug name was mentioned in the allergy section, we could infer that the drug belongs … The prevalence of each drug and drug class was calculated and compared by sex and race/ethnicity. … of 1.95 drug allergies per patient. … to ≥2 drug classes.

39. Chronic Obstructive Pulmonary Disease Exacerbations (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/long-term-care/one-pager-COPD.pdf
    June 02, 2021 - Doxycycline – Drug Summary. … Doxycycline: Drug information. … Food & Drug Administration. … February 2018. https://www.fda.gov/drugs/drug-safety- and-availability/fda-drug-safety-communication- … /contents/doxycycline-drug-information?

40. Final Progress Report: Medication Safety in Primary Care Practice Translating Research Into Practice (MS-TRIP) (pdf file)
    www.ahrq.gov/sites/default/files/2024-02/ornstein-report.pdf
    January 01, 2024 - potentially inappropriate therapy, avoiding potentially inappropriate dosages, avoiding potential drug-drug … drug events. … Practice-level avoidance of potential drug- drug interactions and potentially inappropriate dosages were … interactions, drug-disease interactions, and monitoring or prevention of adverse drug events (ADEs) … drug events.